Today's Pre-Market Stock Movers: ORCL, RENT, U, AKRO and More

• $Planet Labs PBC (PL.US)$ +11.3%, $Core & Main (CNM.US)$ +6.1%, $Regal Rexnord (RRX.US)$ +2% (reaffirms outlook), $Oracle (ORCL.US)$ +1.6%

• $Akouos (AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)

• $Catalyst Pharmaceuticals (CPRX.US)$ +7.7% (to join S&P SmallCap 600)

• $Avita Medical (RCEL.US)$ +4.8% (trial results for RECELL System)

• $Angi Inc (ANGI.US)$ +3.4% (reports August performance metrics)

• $Cheniere Energy (LNG.US)$ +3.3% (provides long-term plan targets; increases FY22 guidance; increases share repurchase authorization by $4 bln)

• $Zymeworks (ZYME.US)$ +3% (reports preliminary Phase 1 results for Zanidatamab Zovodotin)

• $UBS Group (UBS.US)$ +2.8% (provides update on its 2022 capital returns to shareholders; raises dividend)

• $Applovin (APP.US)$ +2.7% (APP confirms it does not intend to submit another proposal to combine with $Unity Software (U.US)$ and has withdrawn its initial proposal)

• $Rocket Lab (RKLB.US)$ +1.9% (preparing to launch its 30th Electron rocket and 150th satellite to space)

• $Peloton Interactive (PTON.US)$ +1.2% (co-founders John Foley and Hisao Kushi step down; names new chairperson)

• $Rent the Runway (RENT.US)$ -24.5% (also announces restructuring plan; includes 24% workforce reduction), $Braze (BRZE.US)$ -5.9%, $Eastman Chemical (EMN.US)$ -3% (guidance), $Cardinal Health (CAH.US)$ -1.1% (reaffirms outlook)

• $Cardiff Oncology (CRDF.US)$ -19.6% (announces plans for trial in mCRC in ongoing Phase lb/2 trial)

• $Revance Therapeutics(Delisted) (RVNC.US)$ -6.4% (prices offering of 8 mln shares of common stock at $25.00 per share)

• $Driven Brands (DRVN.US)$ -6.2% (prices secondary offering of 7.0 mln shares)

• $First Watch Restaurant (FWRG.US)$ -4.1% (files for 4.5 mln share offering by selling shareholders)

• $Crestwood Equity (CEQP.US)$ -3% (AM to acquire Marcellus Shale assets from $Crestwood Equity (CEQP.US)$ for $205 mln; prices secondary offering of 11.4 mln common units by certain subsidiaries of Chord Energy (CHRD) for gross proceeds of $306.7 mln)

• $MiMedx (MDXG.US)$ -2.5% (receives reimbursement approval from Japanese Ministry of Health for EPIFIX)

• $ESCO Technologies (ESE.US)$ -2.5% (CEO to retire names new CEO)

• $Unity Software (U.US)$ -1.9% (APP confirms it does not intend to submit another proposal to combine with Unity and has withdrawn its initial proposal)